MN SF1518 | 2019-2020 | 91st Legislature

Status

Sponsorship: Bipartisan Bill
Status: Introduced on February 21 2019 - 25% progression, died in committee
Action: 2019-02-21 - Referred to Health and Human Services Finance and Policy
Pending: Senate Health and Human Services Finance and Policy Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Wholesale drug distributor or manufacturer price gouging prohibition; board of pharmacy, commissioner of human services, and health plan companies attorney general notification of prescription drug price increases; attorney general authority to obtain drug pricing information and action authorization; penalties

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Wholesale drug distributor or manufacturer price gouging prohibition; board of pharmacy, commissioner of human services, and health plan companies attorney general notification of prescription drug price increases; attorney general authority to obtain drug pricing information and action authorization; penalties

Sponsors


History

DateChamberAction
2019-02-21SenateReferred to Health and Human Services Finance and Policy
2019-02-21SenateIntroduction and first reading

Same As/Similar To

HF4 (Similar To) 2020-03-26 - Committee report, without further rec to amend, re-refer to Ways and Means

Minnesota State Sources


feedback